Published in PLoS One on May 15, 2015
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Radiotherapy for glioblastoma in the elderly. N Engl J Med (2007) 5.64
Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol (1984) 4.64
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol (2004) 4.46
Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology (2009) 2.44
Patterns of care in elderly glioblastoma patients. Ann Neurol (2008) 2.17
Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. J Neurosurg (2010) 2.11
Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age. J Neurosurg (2011) 1.84
Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol (2014) 1.77
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis. Clin Neurol Neurosurg (2014) 1.47
Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys (2011) 1.20
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys (2007) 1.18
Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol (2010) 1.12
Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration. Am J Clin Pathol (2009) 1.08
Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials? Am J Clin Oncol (2015) 0.93
Revisiting the role of p53 in primary and secondary glioblastomas. Anticancer Res (2007) 0.90
Assessment and treatment relevance in elderly glioblastoma patients. Neuro Oncol (2014) 0.90
Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study. J Neurooncol (2013) 0.89
Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme. J Clin Neurosci (2013) 0.88
Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys (2014) 0.87
Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide. J Neurooncol (2014) 0.85
Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol (2014) 0.84
A review of management strategies of malignant gliomas in the elderly population. Am J Cancer Res (2014) 0.84
Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas. J Geriatr Oncol (2014) 0.78
Treatment of glioblastoma in elderly patients. CNS Oncol (2014) 0.77